Supplementary Figure 1: Correlation analysis of DKC1 mRNA and dyskerin protein quantity in neuroblastoma cell lines.

Slides:

Advertisements

Similar presentations

MYC/BCL2 protein coexpression contributes inferior outcome in DLBCL

Advertisements

Counts TLR3-PE Counts TLR8-PE Counts TLR9-PE C AB Supplemental Figure 1.

H3.3 and its role in Pediatric Gliomas By: Connor Belson Biology 445.

Co-supervisor: Prof Richard Lock

Figure S1. RNA-seq results for caveolin-1 (Cav1). Upper panel: UCSC genome browser view. Lower panel: quantification o f Cav1 expression based on RNA-seq.

Supplemental figure 1: Correlation coefficients between signal intensities from biological replicates of wild.

Tumor clock protein PER2 as a determinant of survival in patients (pts) receiving oxaliplatin-5-FU- leucovorin as 1st line chemotherapy for metastatic.

Telomerase, Immortalization and Cancer Eric Bankaitis Cancer Bio 169 March 9, 2006 Fig.[9]

Main Figures and Tables. Figure 1 Strategy (shall we make a strategy figure here?? ）

Supplementary Figure 1 Supplementary Figure 1. Kaplan–Meier estimates of recurrence-free survival (RFS) according to the expression of every ten mRNA/lncRNA.

-33 Red bar: tonsil tumour samples, n =14 x2 Green bar: tonsil normal samples, n = 9 x2 A B Supplementary Figure 1. A)Unsupervised HCL analysis was used.

A B C Supplementary Figure S1. Time-dependent assessment of grade, GGI and PAM50 in untreated patients Landmark analyses of the Kaplan-Meier estimates.

BIOLOGICAL MARKERS OF PROGNOSIS IN EWING'S SARCOMA: THE ROLE OF GAL3BP CTOS meeting, Seattle 2007 Katia Scotlandi, Diana Zambelli, Monia Zuntini, and Piero.

Gene expression (fold-increase vs. untreated control) > 7-fold Insulin/Glucose axis-unrelated genes Insulin/Glucose axis-related genes a Supplemental Figure.

Supplementary Figure 1 Supplementary Figure 1. Representative micrographs of migration and invasion assays. miR-452 or si-WWP1 transfectants inhibited.

*** * * * Figure S1 Supplementary Figure 1. Analysis of JARID1A–D mRNA levels showed that JARID1D knockdown had insignificant or weak effects on expression.

Main Figures and Tables

Supplementary figure 5.

Figure S1. A B C Survival probability (%) P = 0.21 P = 0.37 P = 0.12

Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and βIII-Tubulin Between.

TUMOR PD-L1 TIL PD-L1 TUMOR & TIL PD-L1 Age Low High P value R Pearson

C Supplemental Figure S2.. C Supplemental Figure S2.

Fig. 1 Increased MIR155HG expression correlates with glioma grade and mesenchymal transition and confers a poor prognosis in GBM patients. (A) The level.

Potential Molecular Mechanisms for Improved Prognosis and Outcome with Neoadjuvant Chemotherapy Prior to Laparoscopical Radical Hysterectomy for Patients.

Volume 15, Pages (February 2017)

Figure 3. Sensitivity of the gastric carcinoma cell line N87 for trastuzumab in comparison with the breast cancer cell line SKBR-3. (A) Dose–response curves.

Hallett, et al., - Supplementary Figure 1

Figure 2 Disease-free survival in patients with normal versus high pretreatment C-reactive protein (CRP) levels. From: Elevated serum levels of C-reactive.

Cell Physiol Biochem 2017;44:1867– DOI: /

Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma Cell Physiol Biochem 2017;44:99–109.

Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence Ashish Singhal, Muralidharan Jayaraman, Danny.

KDM1B Expression in Richardson Breast 2

Chapter 08 The T Cell Receptor: Proteins and Genes

expression surface markers

A B C Supplementary figure S7

Supplementary Figure 1 A B C siControl siRNF31 siRNF31+siP53 siControl

Supplementary Table 1 Sequences of the primer used for q-PCR analysis

Figure S1: Gene importance plot derived from Variable/ Feature selection using machine learning on the training dataset. MeanDecreaseGini is the measure.

Figure 2 The association between CD8+ T‑cell density of the tumour

The mRNA stem cell signature.

Molecular Therapy - Nucleic Acids

Volume 2, Issue 5, Pages (November 2002)

Volume 24, Issue 1, Pages (January 2016)

Изразеното в настоящата презентация мнение обвързва единствено автора и не представлява официално становище на Комисията за финансов надзор Данил Джоргов.

Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and βIII-Tubulin Between.

Figure S2 Supplementary data a b CCA1 CCA2 CCA4 CCA3 CCA5 EGFR HER2

Interactions between Dyskerin expression and known prognosis factors

A B Supplementary Figure 1

Volume 6, Issue 3, Pages (September 2004)

palpable tumor in nudes

8 slides for 4 panels (A-D)

Fig. 1. miR-370 was downregulated, and GUCD1 was upregulated in HCC

mRNA level as % relative to

Bernard et al, Supplementary Figure S1

Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang Molecular Therapy

Volume 40, Issue 5, Pages (December 2010)

Supplementary Table 1. Summary of surface marker expression of adherent (A) and sphere-forming MRT cell lines (B), and primary tumors (C). A Sample CD146.

Long Noncoding RNAs and Hepatocellular Carcinoma

Functional classification and visualization of differentially expressed genes. Functional classification and visualization of differentially expressed.

Loss of Proapoptotic Bcl-2-Related Multidomain Proteins in Primary Melanomas Is Associated with Poor Prognosis Lothar F. Fecker, Christoph C. Geilen,

Supplementary Figure S1

NB PC12 PC12+NGF C6 A B C D E F G H I J K L Residual Normality

EN1 expression in breast cancer and clinical outcome.

Inter-laboratory cohort Prognostication cohort

Transcripts enriched and depleted in NB TICs compared with SKPs and other tumor tissues. Transcripts enriched and depleted in NB TICs compared with SKPs.

MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients treated with tamoxifen. MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients.

High-risk neuroblastoma molecular subtypes classification and inference of master regulators. High-risk neuroblastoma molecular subtypes classification.

MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.

Fig. 1. FAM83H over-expression is associated with poor prognosis of CC

DYNLRB1, AIMP1, and NPIPA1 expression correlate with survival in neuroblastoma. DYNLRB1, AIMP1, and NPIPA1 expression correlate with survival in neuroblastoma.

Presentation transcript:

Supplementary Figure 1: Correlation analysis of DKC1 mRNA and dyskerin protein quantity in neuroblastoma cell lines

B A Supplementary Figure 2: Correlation analysis of telomerase activity gene expression in neuroblastoma cells

Supplementary Figure 3: Correlation analysis of TERT and MYC gene expression in neuroblastoma tumor samples

Supplementary Figure 4: High DKC1 expression is a marker of poor prognosis in neuroblastoma OS C DKC1 MedianDKC1 Upper Decile B D OS Overall survival probability Days from diagnosis Overall survival probability Days from diagnosis Low DKC1 High DKC1 Low DKC1 High DKC1 P < B EFS DKC1 MedianDKC1 Upper Decile A Event-free survival probability Days from diagnosis Event-free survival probability Days from diagnosis Low DKC1 High DKC1 Low DKC1 High DKC1 EFS P <

Supplementary Figure 5: Analysis of TERT expression in neuroblastoma tumor samples Kocak (n=477) Days from diagnosis High TERT Low TERT P < Days from diagnosis Event-free survival probability High TERT Low TERT P < EFSOS Overall survival probability BA

A B Supplementary Figure 7: Upregulation of p21 cip1 in NB69, but not SK-N-BE(2) cells following down regulation of dyskerin NB69 SK-N-BE(2)

Sub G1/0 Events FL-2 (PI) NB69 ScD2 Events D3 FL-2 (PI) A SK-N-BE(2) Events ScD2D3 FL-2 (PI) C Sub G1/0 Events FL-2 (PI) SK-N-BE(2) F D NB69 B E SK-N-BE(2) Supplementary Figure 8: Cell cycle and viability following downregulation of dyskerin ScD2D3 D2 D3 NB69 Sc